StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMApr 30, 2026, 07:02 AM

UNCY to hold Annual Meeting June 19, 2026; Director Aggarwal resigned

AI Summary

Unicycive Therapeutics, Inc. will hold its Annual Meeting of Stockholders on June 19, 2026, to elect three directors and ratify the appointment of Grassi & Co. CPAs, P.C. as its independent registered public accounting firm for fiscal year ending December 31, 2026. The company also announced the resignation of independent director Gaurav Aggarwal on April 6, 2026, and plans to appoint new independent directors to its Board and committees by October 3, 2026, to comply with Nasdaq rules.

Key Highlights

  • Annual Meeting of Stockholders scheduled for June 19, 2026, at 10:00 a.m. PDT.
  • Stockholders to elect three members to the Board of Directors.
  • Stockholders to ratify Grassi & Co. CPAs, P.C. as independent auditor for FY2026.
  • Record date for voting is April 27, 2026.
  • Independent director Gaurav Aggarwal resigned on April 6, 2026.
  • Company intends to appoint a new independent director and committee members by October 3, 2026.
  • Proxy solicitation agent Alliance Advisors retained at an approximate cost of $14,500 plus $6,000 for expenses.